Our company was established to promote the Teijin Groupʼs growth strategy in healthcare business by taking over the medical division of C.I.Takiron Co.,Ltd. in July 2017.

Currently, our company manufactures and distributes the highest quality of bioresorbable materials that can be used in several fields, such as orthopedic surgery, thoracic surgery, plastic and reconstructive/oral and maxillofacial surgery, and neurosurgery.

Our company intend in developing new implantable medical devices by utilizing the macromolecular chemistry technology of material business group, and, collaborating with the experience and marketing network of healthcare business group of Teijin.

Furthermore, taking advantage of its characteristics (combination of manufacturing with distributing) we intend to make further contribution in medical healthcare field by improving company structure by enabling quick commercialization on the requests or idea arising from the market.

Moreover, we will support healthcare professionals working as members of medical teams and strive to improve patients' QOL.